# Development of Biomarkers or Composite Biomarkers for Neurological and Neuromuscular Disorders (R61/R33 - Clinical Trial Optional)

Federal grant opportunity, via Kontrakk.

- **Agency:** National Institutes of Health
- **Opportunity number:** PAR-25-024
- **Status:** posted
- **Opens:** October 28, 2024
- **Closes:** January 7, 2028
- **CFDA:** 93.853, 93.866
- **View on Kontrakk:** https://kontrakk.com/grants/356874

## Description

No description provided.